Neurogenic mechanisms underlying the rapid onset of sympathetic responses to intermittent hypoxia

Journal of Applied Physiology

Volumn 119, Issue 12, 2015, Pages 1441-1448

  Mifflin, Steve ^a   Cunningham, J Thomas ^a   Toney, Glenn M ^b  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b University of Texas Health Science Center   (United States)

Author keywords

Central nervous system; Intermittent hypoxia; Sympathetic nervous system

Indexed keywords

ADRENERGIC SYSTEM; ANIMAL; CENTRAL NERVOUS SYSTEM; HUMAN; HYPOXIA; PATHOPHYSIOLOGY;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; HYPOXIA; SYMPATHETIC NERVOUS SYSTEM;

EID: 84957887039     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00198.2015     Document Type: Review

References (67)

1. Almado CE, Machado BH, Leao RM. Chronic intermittent hypoxia depresses afferent neurotransmission in NTS neurons by a reduction in the number of active synapses. J Neurosci 32: 16737-16746, 2012.
2. Bao G, Randhawa PM, Fletcher EC. Acute blood pressure elevation during repetitive hypocapnic and eucapnic hypoxia in rats. J Appl Physiol 82: 1071-1078, 1997.
3. Bathina CS, Rajulapati A, Franzke M, Yamamoto K, Cunningham JT, Mifflin S. Knockdown of tyrosine hydroxylase in the nucleus of the solitary tractreduces elevated blood pressure during chronic intermittent hypoxia. Am J Physiol Regul Integr Comp Physiol 305: R1031-R1039, 2013.
4. Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 50: 417-423, 2007.
5. Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE, Peter JH. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107: 68-73, 2003.
6. Bratel T, Wennlund A, Carlstrom K. Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP). Respir Med 93: 1-7, 1999.
7. Buckley TM, Schatzberg AF. Review: on the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab 90: 3106-3114, 2005.
8. Carneiro G, Togeiro SM, Hayashi LF, Ribeiro-Filho FF, Ribeiro AB, Tufik S, Zanella MT. Effect of continuous positive airway pressure therapy on hypothalamic-pituitary-adrenal axis function and 24-h blood pressure profile in obese men with obstructive sleep apnea syndrome. Am J Physiol Endocrinol Metab 295: E380-E384, 2008.
9. Carreras A, Kayali F, Zhang J, Hirotsu C, Wang Y, Gozal D. Metabolic effects of intermittent hypoxia in mice: steady versus highfrequency applied hypoxia daily during the rest period. Am J Physiol Regul Integr Comp Physiol 303: R700-R709, 2012.
10. Coleman CG, Wang G, Park L, Anrather J, Delagrammatikas G, Chan J, Zhou J, Iadecola C, Pickel VM. Chronic intermittent hypoxia induces NMDA receptor-dependent plasticity and suppresses nitric oxide signaling in the mouse hypothalamic paraventricular nucleus. J Neurosci 30: 12103-12112, 2010.
11. Cunningham JT, Knight WD, Mifflin SW, Nestler EJ. An essential role for DeltaFosB in the median preoptic nucleus in the sustained hypertensive effects of chronic intermittent hypoxia. Hypertension 60: 179-187, 2012.
12. Cutler MJ, Swift NM, Keller DM, Wasmund WL, Burk JR, Smith ML. Periods of intermittent hypoxic apnea can alter chemoreflex control of sympathetic nerve activity in humans. Am J Physiol Heart Circ Physiol 287: H2054-H2060, 2004.
13. Cutler MJ, Swift NM, Keller DM, Wasmund WL, Smith ML. Hypoxia-mediated prolonged elevation of sympathetic nerve activity after periods of intermittent hypoxia. J Appl Physiol 96: 754-761, 2004.
14. da Silva AQ, Fontesa MA, Kanagy NL. Chronic infusion of angiotensin receptor antagonists in the hypothalamic paraventricular nucleus prevents hypertension in a rat model of sleep apnea. Brain Res 1368: 231-238, 2011.
15. de Paula PM, Tolstykh G, Mifflin SW. Chronic intermittent hypoxia alters NMDA and AMPA-evoked currents in NTS neurons receiving carotid body chemoreceptor inputs. Am J Physiol Regul Integr Comp Physiol 292: R2259-R2265, 2007.
16. Dempsey JA, Veasey SC, Morgan BJ, O'Donnell CP. Pathophysiology of sleep apnea. Physiol Rev 90: 47-112, 2010.
17. Dick TE, Hsieh YH, Morrison S, Coles SK, Prabhakar N. Entrainment pattern between sympathetic and phrenic nerve activities in the Sprague-Dawley rat: hypoxia-evoked sympathetic activity during expiration. Am J Physiol Regul Integr Comp Physiol 286: R1121-R1128, 2004.
18. Dick TE, Hsieh YH, Wang N, Prabhakar N. Acute intermittent hypoxia increases both phrenic and sympathetic nerve activities in the rat. Exp Physiol 92: 87-97, 2007.
19. Fletcher EC, Bao G, Li R. Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 34: 309-314, 1999.
20. Fletcher EC, Lesske J, Behm R, Miller CC 3rd, Stauss H, Unger T. Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea. J Appl Physiol 72: 1978-1984, 1992.
21. Fletcher EC, Lesske J, Qian W, Miller CC, Unger T. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension 19: 555-561, 1992.
22. Fletcher EC, Orolinova N, Bader M. Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system. J Appl Physiol 92: 627-633, 2002.
23. Greenberg HE, Sica A, Batson D, Scharf SM. Chronic intermittent hypoxia increases sympathetic responsiveness to hypoxia and hypercapnia. J Appl Physiol 86: 298-305, 1999.
24. Hiestand DM, Britz P, Goldman M, Phillips B. Prevalence of symptoms and risk of sleep apnea in the US population: results from the National Sleep Foundation Sleep in America 2005 poll. Chest 130: 780-786, 2006.
25. Huang J, Lusina S, Xie T, Ji E, Xiang S, Liu Y, Weiss JW. Sympathetic response to chemostimulation in conscious rats exposed to chronic intermittent hypoxia. Respir Physiol Neurobiol 166: 102-106, 2009.
26. Jun JC, Shin MK, Devera R, Yao Q, Mesarwi O, Bevans-Fonti S, Polotsky VY. Intermittent hypoxia-induced glucose intolerance is abolished by alpha-adrenergic blockade or adrenal medullectomy. Am J Physiol Endocrinol Metab 307: E1073-E1083, 2014.
27. Kline D, Ramirez-Navarro A, Kunze DL. Adaptive depression in synpatic transmission in the nucleus of the solitary tract after in vivo chronic intermittent hypoxia: Evidence for homeostatic plasticity. J Neurosci 27: 4663-4673, 2007.
28. Knight WD, Little JT, Carreno FR, Toney GM, Mifflin SW, Cunningham JT. Chronic intermittent hypoxia increases blood pressure and expression of FosB/deltaFosB in central autonomic regions. Am J Physiol Regul Integr Comp Physiol 301: R131-R139, 2011.
29. Knight WD, Saxena A, Shell B, Nedungadi TP, Mifflin SW, Cunningham JT. Central losartan attenuates increases in arterial pressure and expression of FosB/FosB along the autonomic axis associated with chronic intermittent hypoxia. Am J Physiol Regul Integr Comp Physiol 305: R1051-R1058, 2013.
30. Kuniyoshi FH, Somers V. Sleep apnea in hypertension: when, how, and why should we treat? Hypertension 47: 818-819, 2006.
31. Lanfranco F, Gianotti L, Pivetti S, Navone F, Rossetto R, Tassone F, Gai V, Ghigo E, Maccario M. Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph function. Clin Endocrinol 60: 41-48, 2004.
32. Ma S, Mifflin SW, Cunningham JT, Morilak DA. Chronic intermittent hypoxia sensitizes acute hypothalamic-pituitary-adrenal stress reactivity and Fos induction in the rat locus coeruleus in response to subsequent immobilization stress. Neuroscience 154: 1639-1647, 2008.
33. McNicholas WT. Cardiovascular outcomes of CPAP therapy in obstructive sleep apnea syndrome. Am J Physiol Regul Integr Comp Physiol 293: R1666-R1670, 2007.
34. Moreau JM, Ciriello J. Effects of acute intermittent hypoxia on energy balance and hypothalamic feeding pathways. Neuroscience 253: 350-360, 2013.
35. Narkiewicz K, Somers V. The sympathetic nervous system and obstructive sleep apnea. J Hypertens 15: 1613-1619, 1997.
36. Narkiewicz K, van de Borne PJ, Montano N, Dyken ME, Phillips BG, Somers VK. Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 97: 943-945, 1998.
37. Narkiewicz K, van de Borne PJ, Pesek CA, Dyken ME, Montano N, Somers VK. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 99: 1183-1189, 1999.
38. Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98: 772-776, 1998.
39. Olivan MV, Bonagamba LG, Machado BH. Involvement of the paraventricular nucleus of the hypothalamus in the pressor response to chemoreflex activation in awake rats. Brain Res 895: 167-172, 2001.
40. Palkovits M. Interconnections between the neuroendocrine hypothalamus and the central autonomic system. Front Neuroendocrinol 20: 270-295, 1999.
41. Parati G, Lombardi C, Narkiewicz K. Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk. Am J Physiol Regul Integr Comp Physiol 293: R1671-R1683, 2007.
42. Parish JM, Somers VK. Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc 79: 1036-1046, 2004.
43. Peng YJ, Yuan G, Khan S, Nanduri J, Makarenko VV, Reddy VD, Vasavda C, Kumar GK, Semenza GL, Prabhakar NR. Regulation of hypoxia-inducible factor-α isoforms and redox state by carotid body neural activity in rats. J Physiol 592: 3841-3858, 2014.
44. Phillips BG, Somers VK. Hypertension and obstructive sleep apnea. Curr Hypertens Rep 5: 380-385, 2003.
45. Phillips SA, Olson EB, Morgan BJ, Lombard JH. Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 286: H388-H393, 2004.
46. Prabhakar N, Dick TE, Nanduri N, Kumar GK. Systemic, cellular and molecular analysis of chemoreflex-mediated sympathoexcitation by chronic intermittent hypoxia. Exp Physiol 92: 39-44, 2006.
47. Prabhakar NR, Balan KV, Tjoe SS, Martin RJ, LaManna JC, Haxhiu MA, Dick TE. Increased vasopressin transmission from the paraventricular nucleus to the rostral medulla augments cardiorespiratory outflow in chronic intermittent hypoxia-conditioned rats. J Physiol 588: 725-740, 2010.
48. Prabhakar NR, Peng YJ, Jacono FJ, Kumar GK, Dick TE. Cardiovascular alterations by chronic intermittent hypoxia: importance of carotid body chemoreflexes. Clin Exp Pharmacol Physiol 32: 447-449, 2005.
49. Przybylowski T, Bielicki P, Kumor M, Hildebrand K, Maskey-Warzechowska M, Korczynski P, Chazan R. Exercise capacity in patients with obstructive sleep apnea syndrome. J Physiol Pharmacol 58, Suppl 5: 563-574, 2007.
50. Reddy MK, Patel KP, Schultz HD. Differential role of the paraventricular nucleus of the hypothalamus in modulating the sympathoexcitatory component of peripheral and central chemoreflexes. Am J Physiol Regul Integr Comp Physiol 289: R789-R797, 2005.
51. Rinaman L. Hindbrain noradrenergic A2 neurons: diverse roles in autonomic, endocrine, cognitive, and behavioral functions. Am J Physiol Regul Integr Comp Physiol 300: R222-R235, 2011.
52. Rizzi CF, Cintra F, Risso T, Pulz C, Tufik S, de Paola A, Poyares D. Exercise capacity and obstructive sleep apnea in lean subjects. Chest 137: 109-114, 2010.
53. Saxena A, Little JT, Nedungadi TP, Cunningham JT. Angiotensin II type 1 1A receptors in subfornical organ contributes towards chronic intermittent hypoxia associated sustained increase in mean arterial pressure. Am J Physiol Heart Circ Physiol 308: H435-H446, 2015.
54. Scheuer DA, Bechtold AG. Glucocorticoids potentiate central actions of angiotensin to increase arterial pressure. Am J Physiol Regul Integr Comp Physiol 280: R1719-R1726, 2001.
55. Scheuer DA, Bechtold AG, Shank SS, Akana SF. Glucocorticoids act in the dorsal hindbrain to increase arterial pressure. Am J Physiol Heart Circ Physiol 286: H458-H467, 2004.
56. Sharpe AL, Andrade MA, Herrera-Rosales M, Britton SL, Koch LG, Toney GM. Rats selectively bred for differences in aerobic capacity have similar hypertensive responses to chronic intermittent hypoxia. Am J Physiol Heart Circ Physiol 305: H403-H409, 2013.
57. Sharpe AL, Calderon AS, Andrade MA, Cunningham JT, Mifflin SW, Toney GM. Chronic intermittent hypoxia increases sympathetic control of blood pressure: role of neuronal activity in the hypothalamic paraventricular nucleus. Am J Physiol Heart Circ Physiol 305: H1772-H1780, 2013.
58. Silva AQ, Schreihofer AM. Altered sympathetic reflexes and vascular reactivity in rats after exposure to chronic intermittent hypoxia. J Physiol 589: 1463-1476, 2011.
59. Snow JB, Kitzis V, Norton CE, Torres SN, Johnson KD, Kanagy NL, Walker BR, Resta TC. Differential effects of chronic hypoxia and intermittent hypocapnic and eucapnic hypoxia on pulmonary vasoreactivity. J Appl Physiol 104: 110-118, 2008.
60. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96: 1897-1904, 1995.
61. Toney GM, Cunningham JT, Mifflin SW. Early neural adaptations to intermittent hypoxia: Triggers for the pathophysiology of sleep apnea. Recent Advances in Cardiovascular Research: From Sleep to Exercise, edited by Ally A, Maher TJ, Wyss JM. Kerala, India: Transworld Research Network. 2010, chapt. 5, p. 1-22.
62. Wang Y, Guo SZ, Bonen A, Li RC, Kheirandish-Gozal L, Zhang SX, Brittian KR, Gozal D. Monocarboxylate transporter 2 and stroke severity in a rodent model of sleep apnea. J Neurosci 31: 10241-10248, 2011.
63. Xie A, Skatrud JB, Puleo DS, Morgan BJ. Exposure to hypoxia produces long-lasting sympathetic activation in humans. J Appl Physiol 91: 1555-1562, 2001.
64. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353: 2034-2041, 2005.
65. Zhang W, Carreno FR, Cunningham JT, Mifflin SW. Chronic sustained and intermittent hypoxia reduce function of ATP-sensitive potassium channels in nucleus of the solitary tract. Am J Physiol Regul Integr Comp Physiol 295: R1555-R1562, 2008.
66. Zoccal DB, Bonagamba LG, Antunes-Rodrigues J, Machado BH. Plasma corticosterone levels is elevated in rats submitted to chronic intermittent hypoxia. Auton Neurosci 134: 115-117, 2007.
67. Zoccal DB, Simms AE, Bonagamba LGH, Braga VA, Pickering AE, Paton JF, Machado BH. Increased sympathetic outflow in juvenile rats submitted to chronic intermittent hypoxia correlates with enhanced expiratory activity. J Physiol 586: 3253-3265, 2008.